ASH highlights 2022 —multiple myeloma

SummaryThe 64th annual meeting was held in New Orleans, Louisiana from December 10 –13, 2022. More than 150 abstracts concerning multiple myeloma have been presented, mirroring the rapid progression, and deepening of our understanding of this disease.Evolution in treatment options includes new therapeutic regimens incorporating established drugs as well as entirely newly discovered substances, targeting malignant plasma cells utilizing the power of the immune system. In the following, a personal shortcut of hot topics is presented, focusing on data from large clinical trials which have the potency to change clinical practice as well as on new treatment options which may impact future strategies to achieve deep and durable responses aiming to pave the way to potential cure.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research